Escala Medical Ltd., proudly announces its selection as a recipient of a €5.5 million in grant and equity investment from the European Innovation Council. Escala is at the forefront of the pelvic organ prolapse (POP) treatment revolution....
Medtronic plc(opens new window) (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on the MiniMed™ 780G system. These latest data sets, which evaluated the system across a wide range of users, including historically challenging younger patients, those not meeting glycemic goals, and individuals using a simplified meal announcement leveraging fixed carbohydrate amounts instead of exact carb calculations, found that the pro...
